Raymond James Boosts Intuitive Surgical (NASDAQ:ISRG) Price Target to $688.00

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) had its target price lifted by research analysts at Raymond James from $560.00 to $688.00 in a research note issued on Friday,Benzinga reports. The firm currently has an "outperform" rating on the medical equipment provider's stock. Raymond James' price target suggests a potential upside of 17.80% from the company's previous close.

Several other brokerages have also commented on ISRG. BTIG Research increased their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a research note on Tuesday, November 26th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research report on Friday, October 18th. Oppenheimer reaffirmed a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. JPMorgan Chase & Co. increased their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a report on Friday. Finally, Morgan Stanley raised Intuitive Surgical from an "equal weight" rating to an "overweight" rating and raised their price objective for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $583.83.

Intuitive Surgical Stock Down 4.0 %

Shares of NASDAQ:ISRG traded down $24.61 during trading on Friday, reaching $584.05. 4,350,539 shares of the company traded hands, compared to its average volume of 1,997,346. Intuitive Surgical has a 1-year low of $364.17 and a 1-year high of $616.00. The firm has a market cap of $208.03 billion, a P/E ratio of 93.90, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The firm has a fifty day simple moving average of $546.03 and a 200 day simple moving average of $503.38.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the company's stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the sale, the executive vice president now directly owns 5,506 shares of the company's stock, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company's stock, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 42,475 shares of company stock worth $22,070,807 in the last 90 days. 0.90% of the stock is owned by company insiders.

Institutional Investors Weigh In On Intuitive Surgical

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $26,000. Godsey & Gibb Inc. lifted its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the 3rd quarter valued at $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $36,000. Finally, Capital Performance Advisors LLP bought a new stake in shares of Intuitive Surgical during the third quarter worth $38,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.